AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-99 |
Results: 76-99/99

Authors: FJAERTOFT G EWALD U FOUCARD T HAKANSSON L VENGE P
Citation: G. Fjaertoft et al., RECEPTORS FOR PHAGOCYTOSIS AND ADHESION ON NEUTROPHIL GRANULOCYTES INNEWBORN-INFANTS, Pediatric research, 36(1), 1994, pp. 10000013-10000013

Authors: KUIVALAINEN E VENGE P ANDERSSON S
Citation: E. Kuivalainen et al., INCREASED PULMONARY GRANULOCYTE ACTIVATION IN PATENT DUCTUS-ARTERIOSUS IN PREMATURE-INFANTS, Pediatric research, 35(2), 1994, pp. 280-280

Authors: XU SY PETERSSON CGB CARLSON M VENGE P
Citation: Sy. Xu et al., THE DEVELOPMENT OF AN ASSAY FOR HUMAN NEUTROPHIL LIPOCALIN (HNL) - TOBE USED AS A SPECIFIC MARKER OF NEUTROPHIL ACTIVITY IN-VIVO AND VITRO, Journal of immunological methods, 171(2), 1994, pp. 245-252

Authors: PAUKSEN K ELFMAN L ULFGREN AK VENGE P
Citation: K. Pauksen et al., SERUM LEVELS OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN BACTERIAL AND VIRAL-INFECTIONS, AND IN ATYPICAL PNEUMONIA, British Journal of Haematology, 88(2), 1994, pp. 256-260

Authors: HOGLUND M SIMONSSON B SMEDMYR B OBERG G VENGE P
Citation: M. Hoglund et al., THE EFFECT OF RGM-CSF ON NEUTROPHIL AND EOSINOPHIL REGENERATION AFTERABMT AS MONITORED BY CIRCULATING LEVELS OF GRANULE PROTEINS, British Journal of Haematology, 86(4), 1994, pp. 709-716

Authors: CARLSON M OBERG G PETERSON C VENGE P
Citation: M. Carlson et al., RELEASABILITY OF HUMAN HYPEREOSINOPHILIC EOSINOPHILS IS RELATED TO THE DENSITY OF THE CELLS, British Journal of Haematology, 86(1), 1994, pp. 41-47

Authors: FOSSE E MOEN O JOHNSON E SEMB G BROCKMEIER V MOLLNES TE FAGERHOL MK VENGE P
Citation: E. Fosse et al., REDUCED COMPLEMENT AND GRANULOCYTE ACTIVATION WITH HEPARIN-COATED CARDIOPULMONARY BYPASS, The Annals of thoracic surgery, 58(2), 1994, pp. 472-477

Authors: VENGE P
Citation: P. Venge, SERUM MEASUREMENTS OF EOSINOPHIL CATIONIC PROTEIN (ECP) IN BRONCHIAL-ASTHMA, Clinical and experimental allergy, 23, 1993, pp. 3-7

Authors: BONER AL PERONI DG PIACENTINI GL VENGE P
Citation: Al. Boner et al., INFLUENCE OF ALLERGEN AVOIDANCE AT HIGH-ALTITUDE ON SERUM MARKERS OF EOSINOPHIL ACTIVATION IN CHILDREN WITH ALLERGIC-ASTHMA, Clinical and experimental allergy, 23(12), 1993, pp. 1021-1026

Authors: HURST DS VENGE P
Citation: Ds. Hurst et P. Venge, THE PRESENCE OF EOSINOPHIL CATIONIC PROTEIN IN MIDDLE-EAR EFFUSION, Otolaryngology and head and neck surgery, 108(6), 1993, pp. 711-722

Authors: KROEGEL C DEWAR A YUKAWA T VENGE P BARNES PJ CHUNG KF
Citation: C. Kroegel et al., ULTRASTRUCTURAL CHARACTERIZATION OF PLATELET-ACTIVATING FACTOR-STIMULATED HUMAN EOSINOPHILS FROM PATIENTS WITH ASTHMA, Clinical science, 84(4), 1993, pp. 391-399

Authors: CARLSON M PETERSON C VENGE P
Citation: M. Carlson et al., THE INFLUENCE OF IL-3, IL-5, AND GM-CSF ON NORMAL HUMAN EOSINOPHIL AND NEUTROPHIL C3B-INDUCED DEGRANULATION, Allergy, 48(6), 1993, pp. 437-442

Authors: PEDERSEN B DAHL R LARSEN BB VENGE P
Citation: B. Pedersen et al., THE EFFECT OF SALMETEROL ON THE EARLY-PHASE AND LATE-PHASE REACTION TO BRONCHIAL ALLERGEN AND POSTCHALLENGE VARIATION IN BRONCHIAL REACTIVITY, BLOOD EOSINOPHILS, SERUM EOSINOPHIL CATIONIC PROTEIN, AND SERUM EOSINOPHIL PROTEIN-X, Allergy, 48(5), 1993, pp. 377-382

Authors: VENGE P
Citation: P. Venge, EOSINOPHIL AND NEUTROPHIL GRANULOCYTES, Allergy, 48(17), 1993, pp. 39-47

Authors: BUSSE W GODARD P FABBRI L WALKER C VIRCHOW JC BOUSQUET J AHLSTEDT S BURNEY P BONINI S DAHL R VENGE P KAPP A OBYRNE P HOWARTH P AALBERSE R
Citation: W. Busse et al., PATHOPHYSIOLOGY-INFLAMMATION - DISCUSSION, Allergy, 48(17), 1993, pp. 48-49

Authors: VENGE P BUSSE W HOWARTH P FABBRI L BASOMBA A IIKURA Y BOMAN G ROSENHALL L OBYRNE P BJORKSTEN B ZIMMERMAN B GODARD P URBANEK R SCHULTZEWERNINGHAUS G MOTOJIMA S DAHL R
Citation: P. Venge et al., PATHOPHYSIOLOGY-INFLAMMATION - DISCUSSION, Allergy, 48(17), 1993, pp. 62-64

Authors: BJORKSTEN B DAHL R POULSEN L WARNER J BOUSQUET J VENGE P JOHANSSON SGO HAAHTELA T ROSENHALL L BONINI S AHLSTEDT S OBYRNE P FABBRI L HARGREAVE F MAKINO S MOTOJIMA S SEARS M SKOOGH BE KIPS J BURNEY P ORTOLANI C
Citation: B. Bjorksten et al., NEW POSSIBILITIES IN MONITORING INFLAMMATION IN ASTHMA - DISCUSSION, Allergy, 48(17), 1993, pp. 84-86

Authors: SCHMEKEL B VENGE P
Citation: B. Schmekel et P. Venge, MARKERS FOR EOSINOPHILS AND T-LYMPHOCYTES AS PREDICTORS OF LATE ASTHMATIC RESPONSE, Allergy, 48(17), 1993, pp. 94-97

Authors: OBYRNE P SCHMEKEL B KAPP A AHLSTEDT S WAHN U FABBRI L MAKINO S LEVISCHAFFER F VENGE P DAHL R WARNER J JOHANSSON SGO HED J URBANEK R BOUSQUET J BONINI S
Citation: P. Obyrne et al., EXAMPLES OF MONITORING OF INFLAMMATION IN ASTHMA - DISCUSSION, Allergy, 48(17), 1993, pp. 110-111

Authors: OBYRNE P VENGE P POULSEN L BOUSQUET J VIRCHOW C WARNER J ZIMMERMAN B BASOMBA A RAK S IIKURA Y BONINI S AALBERSE R BURNEY P SKOOGH BE BJORKSTEN B SEARS M HED J
Citation: P. Obyrne et al., EXAMPLES OF MONITORING OF INFLAMMATION IN ASTHMA - DISCUSSION, Allergy, 48(17), 1993, pp. 143-145

Authors: VENGE P AHLSTEDT S
Citation: P. Venge et S. Ahlstedt, CONSEQUENCES - QUALITY ASSURANCE AND SOCIOECONOMICS - SUMMARY OF CONCLUDING DISCUSSION, Allergy, 48(17), 1993, pp. 164-164

Authors: LINDEN M RASMUSSEN JB PIITULAINEN E TUNEK A LARSON M TEGNER H VENGE P LAITINEN LA BRATTSAND R
Citation: M. Linden et al., AIRWAY INFLAMMATION IN SMOKERS WITH NONOBSTRUCTIVE AND OBSTRUCTIVE CHRONIC-BRONCHITIS, The American review of respiratory disease, 148(5), 1993, pp. 1226-1232

Authors: VENGE P CARLSON M KARAWAJCZYK M KAMPE M PAUKSEN K PETERSON CGB STALENHEIM G
Citation: P. Venge et al., EVIDENCE OF DIFFERENTIAL RELEASE OF EOSINOPHIL GRANULE PROTEINS, ECP AND EPO, INVIVO, The American review of respiratory disease, 147(4), 1993, pp. 383-383

Authors: MOHAMED AO HASHIM MK NILSSON UR VENGE P
Citation: Ao. Mohamed et al., INCREASED IN-VIVO ACTIVATION OF NEUTROPHILS AND COMPLEMENT IN SICKLE-CELL DISEASE, The American journal of tropical medicine and hygiene, 49(6), 1993, pp. 799-803
Risultati: 1-25 | 26-50 | 51-75 | 76-99 |